etodolac has been researched along with Hepatoblastoma in 1 studies
Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.
Hepatoblastoma: A malignant neoplasm occurring in young children, primarily in the liver, composed of tissue resembling embryonal or fetal hepatic epithelium, or mixed epithelial and mesenchymal tissues. (Stedman, 25th ed)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Etodolac was without influence at concentrations up to 100 μM." | 1.39 | Pharmacological inhibition of beta-catenin in hepatoblastoma cells. ( Armeanu-Ebinger, S; Ellerkamp, V; Fuchs, J; Lieber, J; Nagel, C; Warmann, SW; Wenz, J, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ellerkamp, V | 1 |
| Lieber, J | 1 |
| Nagel, C | 1 |
| Wenz, J | 1 |
| Warmann, SW | 1 |
| Fuchs, J | 1 |
| Armeanu-Ebinger, S | 1 |
1 other study available for etodolac and Hepatoblastoma
| Article | Year |
|---|---|
Pharmacological inhibition of beta-catenin in hepatoblastoma cells.
Topics: Antineoplastic Agents; beta Catenin; Bridged Bicyclo Compounds, Heterocyclic; Celecoxib; Cell Line, | 2013 |